As of March 2026 Theravance Biopharma has a market cap of โน73.23 Billion. This makes Theravance Biopharma the world's 6349th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 27th, 2026 the market cap of Theravance Biopharma was reported to be: